Glenmark Pharmaceuticals Ltd
NSE: GLENMARK BSE: 532296
₹2260
(0.62%)
Sat, 17 Oct 2026, 03:39 pm
Market Cap (in Cr)63980.34
PE Ratio35.48
Dividend0.22
Glenmark Pharmaceuticals Ltd About
Glenmark Pharmaceuticals is primarily engaged in the business of development, manufacturing and marketing of pharmaceutical products. The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities a
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1977
Headquarters
CEO
Glenn Saldanha
Employees
Contact
Website
http://www.glenmarkpharma.com
complianceofficer@glenmarkpharma.com
Phone
91-22-40189999
Location
B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra, 400026